Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 600-401-907 - Provider product page
- Provider
- Rockland Immunochemicals, Inc.
- Proper citation
- Rockland Cat#600-401-907, RRID:AB_2292393
- Product name
- Anti-BORIS (RABBIT) Antibody - 600-401-907
- Antibody type
- Polyclonal
- Vial size
- 100 µl
Submitted references BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.
A cell cycle role for the epigenetic factor CTCF-L/BORIS.
Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.
CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
Janssen SM, Moscona R, Elchebly M, Papadakis AI, Redpath M, Wang H, Rubin E, van Kempen LC, Spatz A
Cell death discovery 2020;6:1
Cell death discovery 2020;6:1
A cell cycle role for the epigenetic factor CTCF-L/BORIS.
Rosa-Garrido M, Ceballos L, Alonso-Lecue P, Abraira C, Delgado MD, Gandarillas A
PloS one 2012;7(6):e39371
PloS one 2012;7(6):e39371
Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.
Macaluso M, Caracciolo V, Rizzo V, Sun A, Montanari M, Russo G, Bellipanni G, Khalili K, Giordano A
Cell cycle (Georgetown, Tex.) 2012 May 1;11(9):1841-50
Cell cycle (Georgetown, Tex.) 2012 May 1;11(9):1841-50
CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
Fiorentino FP, Macaluso M, Miranda F, Montanari M, Russo A, Bagella L, Giordano A
Molecular cancer research : MCR 2011 Feb;9(2):225-33
Molecular cancer research : MCR 2011 Feb;9(2):225-33
BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
Hines WC, Bazarov AV, Mukhopadhyay R, Yaswen P
PloS one 2010 Mar 17;5(3):e9738
PloS one 2010 Mar 17;5(3):e9738
Selective apoptosis of breast cancer cells by siRNA targeting of BORIS.
Dougherty CJ, Ichim TE, Liu L, Reznik G, Min WP, Ghochikyan A, Agadjanyan MG, Reznik BN
Biochemical and biophysical research communications 2008 May 23;370(1):109-12
Biochemical and biophysical research communications 2008 May 23;370(1):109-12
No comments: Submit comment
Supportive validation
- Submitted by
- Rockland Immunochemicals, Inc. (provider)
- Main image
- Experimental details
- Western blot using Rockland's Affinity Purified anti-BORIS antibody shows detection of a predominant band corresponding to BORIS in human tissue lysates (arrowhead). Lane 1 contains lysate from human prostate tissue. Lane 2 contains lysate from human spleen tissue. A predominant band at ~75 kDa is observed. Molecular weight estimation was made by comparison to prestained MW markers as indicated.
- Validation comment
- Western Blot
